The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, science-forward drug development. By reducing reliance on animal models and ...
Research explores how the EU can improve its regulatory framework to drive pharmaceutical innovation
New research from Bayes Business School, in collaboration with biopharmaceuticals company Merck KGaA, suggests member states from the European Union (EU) must work more closely together, provide ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
WASHINGTON, DC - MAY 12: (L-R) National Institutes of Health (NIH) Director Jay Bhattacharya, Administrator for the Centers for Medicare & Medicaid Services (CMS) Mehmet Oz, U.S. President Donald ...
DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By Category, By Indication, By Development Stage, By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback